SCHEMBL18351201

SCHEMBL18351201

CCCC(=O)c1ccc2c(c1)C(CC)(CC)c1cc(C(=NOC(C)=O)c3ccccc3)ccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ MAPT P10636 4/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CTNNB1 P35222 1/20 0.34
▸ WNT3A P56704 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ RXRG P48443 1/20 0.34
▸ PPARG P37231 2/20 0.33
▸ PPARA Q07869 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HSD17B3 P37058 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18012777 0.93 ALDH1A1 (0.39) ALDH1A1KMT2APOLBMAPTKDM4E
SCHEMBL17877640 0.89 ALDH1A1 (0.33) HPGDSMN1; SMN2ALDH1A1KMT2APOLB
SCHEMBL17877625 0.86 HPGD (0.39) HPGDSMN1; SMN2L3MBTL1ALDH1A1KMT2A
SCHEMBL18012819 0.84 CYP2C19 (0.36) ALDH1A1KMT2APOLBMAPTKDM4E
SCHEMBL18012772 0.80 RXRA (0.42) SMN1; SMN2ALDH1A1KMT2APOLBMAPT
SCHEMBL18012625 0.80 MAPT (0.39) HPGDSMN1; SMN2ALDH1A1KMT2APOLB
SCHEMBL17953240 0.79 PDK2 (0.45) HPGDL3MBTL1ALDH1A1MAPTTSHR
SCHEMBL18235854 0.78 PDK2 (0.36) —
SCHEMBL17056225 0.78 KMT2A (0.38) SMN1; SMN2ALDH1A1KMT2APOLBMAPT
SCHEMBL18012642 0.77 RAB9A (0.39) KMT2APOLBMAPTMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160376234-A1 COLORING CURABLE RESIN COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, COMPOUND, AND CATION FUJIFILM CORPORATION (JP) 2016-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160376234-A1 COLORING CURABLE RESIN COMPOSITION, CURED FILM, COLOR FILTER, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, IMAGE DISPLAY DEVICE, COMPOUND, AND CATION O60361, WDR12, SEM1 HPGD 4062/4885SMN1; SMN2 608/4885L3MBTL1 3055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback